Sanofi SA
PAR:SAN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
PAR:SAN
Watchlist
Price: 87.49 EUR 0.42% Market Closed
Market Cap: 107.4B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+33%
Revenue
Forecast
+5%
Operating Income
Forecast
+14%
Net Income
Forecast
+28%

Wall Street
Price Targets

SAN Price Targets Summary
Sanofi SA

Wall Street analysts forecast SAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SAN is 115.97 EUR with a low forecast of 67.67 EUR and a high forecast of 133.35 EUR.

SAN Lowest Forecast
Wall Street Target
67.67 EUR
23% Downside
SAN Average Forecast
Wall Street Target
115.97 EUR
33% Upside
SAN Highest Forecast
Wall Street Target
133.35 EUR
52% Upside
Lowest
Price Target
67.67 EUR
23% Downside
Average
Price Target
115.97 EUR
33% Upside
Highest
Price Target
133.35 EUR
52% Upside
Sanofi SA Competitors:
Price Targets
M
MOC
Molecure SA
201% Upside
G
512
Grand Pharmaceutical Group Ltd
3% Upside
VRNA
Verona Pharma PLC
9% Upside
000423
Dong-E-E-Jiao Co Ltd
43% Upside
M
MOC
Molecure SA
201% Upside
G
512
Grand Pharmaceutical Group Ltd
3% Upside
VRNA
Verona Pharma PLC
9% Upside
000423
Dong-E-E-Jiao Co Ltd
43% Upside
INDOCO
Indoco Remedies Ltd
8% Downside
M
MBX
MBX Biosciences Inc
180% Upside
MARKSANS
Marksans Pharma Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Sanofi SA

For the last 8 years the compound annual growth rate for Sanofi SA's revenue is 3%. The projected CAGR for the next 3 years is 5%.

3%
Past Growth
5%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sanofi SA

For the last 8 years the compound annual growth rate for Sanofi SA's operating income is 3%. The projected CAGR for the next 3 years is 14%.

3%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sanofi SA

For the last 8 years the compound annual growth rate for Sanofi SA's net income is 3%. The projected CAGR for the next 3 years is 28%.

3%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-32%
Average Miss
What are analyst estimates?

See Also

Summary
SAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
SAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SAN stock valuation using valuation multiples.
Wall Street Estimates
SAN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SAN's stock price target?
Price Target
115.97 EUR

According to Wall Street analysts, the average 1-year price target for SAN is 115.97 EUR with a low forecast of 67.67 EUR and a high forecast of 133.35 EUR.

What is Sanofi SA's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Sanofi SA's revenue is 3%. The projected CAGR for the next 3 years is 5%.

What is Sanofi SA's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Sanofi SA's operating income is 3%. The projected CAGR for the next 3 years is 14%.

What is Sanofi SA's Net Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Sanofi SA's net income is 3%. The projected CAGR for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.